A double-blind randomised trial of leuprorelin acetate prior to hysterectomy for dysfunctional uterine bleeding

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 3, 2000, Pages 323-328

  Weeks, Andrew D ^a   Duffy, Sean R G ^a   Walker, James J ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEUPRORELIN; MORPHINE; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OPERATION DURATION; PEROPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SWEAT TEST; UTERUS BLEEDING; UTERUS MYOMA; VAGINAL HYSTERECTOMY;

ADULT; ANALGESICS, OPIOID; BLOOD LOSS, SURGICAL; DOUBLE-BLIND METHOD; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; HYSTERECTOMY; LEIOMYOMA; LEUPROLIDE; MENORRHAGIA; MORPHINE; PAIN, POSTOPERATIVE; PREOPERATIVE CARE;

EID: 0034015243     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb13226.x     Document Type: Article

References (13)

1. Department of Health. Hospital Episode Statistics OPCSR4 1989–1992. London: Department of Health, 1995.
2. Meikle SF, Weston Nugent E, Orleans M. Complications and recovery from laparoscopy-assisted vaginal hysterectomy compared with abdominal and vaginal hysterectomy. Obstet Gynecol 1997; 89: 304–311.
3. Malta WHM, Stabile I, Shaw RW, Campbell S. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotrophin-releasing hormone agonist Buserelin. Fertil Steril 1988; 49: 1083–1085.
4. Lethaby A, Vollenhoven B, Sowter M. Pre-operative gonadotrophin-releasing hormone analogue before hysterectomy or myomectomy for uterine fibroids (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software, 1999.
5. Stovall TG, Muneyyirci-Delale O, Summitt RL, Scialli AR for the Leuprolide Acetate Study Group. GnRH agonist and iron versus placebo and iron in the anaemic patient before surgery for leiomyomas: a randomised controlled trial. Obstet Gynecol 1995; 86: 65–71.
6. Stovall TG, Summit RL, Washburn SA, Ling FW. Gonadotrophin releasing hormone agonist use before hysterectomy. Am J Obstet Gynecol 1994; 170: 1744–1751.
7. Carr BR, Marshburn PB, Weatherall PT et al. An evaluation of the effect of gonadotrophin-releasing hormone analogs and medroxy-progesterone acetate on uterine leiomyomata volume by magnetic resonant imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial. J Clin Endocrinol Metab 1993; 76: 1217–1223.
8. Kurjac A, Kupesic S. Ovarian senescence and its significance on uterine and ovarian perfusion. Fertil Steril 1995; 64: 532–537.
9. Thomas EJ, Okuda KJ, Thomas NM. The combination of a depot gonadotrophin releasing hormone agonist and cyclical hormone replacement therapy for dysfunctional uterine bleeding. Br J Obstet Gynaecol 1991; 98: 1155–1159.
10. Weeks AD, Duffy SRG, Walker JJ. Uterine ultrasonographic changes with gonadotrophin-releasing hormone agonists. Am J Obstet Gynecol 1999; 180: 8–13.
11. Goldstein SR, Horii SC, Snyder JR, Raghavendra BN, Subramanyam B. Estimation of nongravid uterine volume based on a nomogram of gravid uterine volume: its value in gynecological uterine abnormalities. Obstet Gynecol 1988; 72: 86–90.
12. Dicker RC, Greenspan JR, Strauss LT et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. Am J Obstet Gynecol 1982; 144: 841–848.
13. Mistry T, Magos A. First prospective randomised trial comparing vaginal with abdominal hysterectomy. First prospective randomised trial comparing vaginal with abdominal hysterectomy 1998; 105 (supp 17): 110.